Skip to content

Atropine eye drops to decrease myopia progression in children

A randomized controlled trial to evaluate the effect of low dose atropine eyedrop for childhood myopia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/11/007450
Enrollment
40
Registered
2016-11-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Myopia

Interventions

Intervention1: 0.01% Atropine eye drop: one drop of eyedrop in each eyes once at night for 1 year Control Intervention1: 0.5% Carboxymethylcellulose eye drop: one drop of eyedrop in each eyes once at

Sponsors

Dr Rajendra Prasad Centre for Ophthalmic Science
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age 6-12 years Refractive error of spherical equivalent between -2D to -6D in each eye as measured by cycloplegic autorefraction Distance vision correctable to logMAR 0.2 or better in both eyes Normal ocular health other than myopia Informed consent Willing to follow-up

Exclusion criteria

Exclusion criteria: Astigmatism more than -1.5 D as measured by cycloplegic autorefraction Amblyopia Strabismus Allergy to atropine or homatropine Previous or concurrent use of contact lenses, bifocals, progressive addition lenses or other forms of treatment (including atropine) for myopia History of cardiac , neurologic or significant respiratory diseases. Unwilling to give consent/ follow-up

Design outcomes

Primary

MeasureTime frame
myopia progressionTimepoint: 2 weeks 2 months 4 months 8 months 1 year

Secondary

MeasureTime frame
side effectsTimepoint: 2 weeks 2 months 4 months 8 months 1 year

Countries

India

Contacts

Public ContactRohit Agarwal

All India Institute of Medical Sciences

rohitsaxena80@yahoo.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026